Verastem Oncology to Participate in Upcoming Investor Conferences

Rhea-AI Summary

Verastem Oncology (Nasdaq: VSTM) announced its participation in two upcoming virtual investor conferences. The H.C. Wainwright BIOCONNECT Virtual Conference will feature a fireside chat available on-demand starting January 10, 2022, at 7:00 a.m. ET. Additionally, the B. Riley Oncology Conference will host a fireside chat on January 28, 2022, at 9:30 a.m. ET. Webcasts of both chats will be accessible through the investor section of the company's website, www.verastem.com, along with archived presentations following each event.

BOSTON--(BUSINESS WIRE)-- Verastem Oncology (Nasdaq:VSTM), a biopharmaceutical company committed to advancing new medicines for patients battling cancer, today announced that the Company will participate virtually at the following upcoming investor conferences:

• H.C. Wainwright BIOCONNECT Virtual Conference; the fireside chat will be made available for on-demand listening beginning Monday, January 10, 2022 at 7:00 a.m. ET

• B. Riley Oncology Conference; fireside chat on Friday, January 28, 2022 at 9:30 a.m. ET

A webcast of the fireside chats will be available on the investors section of the Company’s website at www.verastem.com. An archived presentation will be made available following each event.

About Verastem Oncology

Verastem Oncology (Nasdaq: VSTM) is a development-stage biopharmaceutical company committed to the development and commercialization of new medicines to improve the lives of patients diagnosed with cancer. Our pipeline is focused on novel small molecule drugs that inhibit critical signaling pathways in cancer that promote cancer cell survival and tumor growth, including RAF/MEK inhibition and focal adhesion kinase (FAK) inhibition. For more information, please visit www.verastem.com.

View source version on businesswire.com: https://www.businesswire.com/news/home/20220104005714/en/

Investors:

Ajay Munshi

Vice President, Corporate Development

+1 781-469-1579

amunshi@verastem.com

Sherri Spear

Argot Partners

+1 212-600-1902

sherri@argotpartners.com

Media:

Lisa Buffington

Corporate Communications

+1 781-292-4205

lbuffington@verastem.com

Source: Verastem Oncology

FAQ

What conferences will Verastem Oncology participate in January 2022?

Verastem Oncology will participate in the H.C. Wainwright BIOCONNECT Virtual Conference on January 10, 2022, and the B. Riley Oncology Conference on January 28, 2022.

When will the fireside chat for the H.C. Wainwright BIOCONNECT Conference be available?

The fireside chat for the H.C. Wainwright BIOCONNECT Conference will be available on-demand starting January 10, 2022, at 7:00 a.m. ET.

What time is Verastem's fireside chat at the B. Riley Oncology Conference?

Verastem's fireside chat at the B. Riley Oncology Conference is scheduled for January 28, 2022, at 9:30 a.m. ET.

Where can I find the webcasts of Verastem's investor conference chats?

The webcasts of Verastem's investor conference chats will be available on the investors section of their website at www.verastem.com.